Bevacizumab-enhanced antitumor effect of 5-fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2-specificity protein 1 pathway

Cancer Science
Wenyue LiuFang Zhou

Abstract

Bevacizumab (Bv) can be used synergistically with fluoropyrimidine-based chemotherapy to treat colorectal cancer. Whether and how it affects the delivery of fluoropyrimidine drugs is unknown. The present study aimed to explore the effect of Bv on the delivery of 5-fluorouracil (5-FU) to tumors and the underlying mechanism from metabolic perspective. Bv enhanced the anti-tumor effects of 5-FU in LoVo colon cancer xenograft mice and increased the 5-FU concentration in tumors without affecting hepatic 5-FU metabolism. Interestingly, Bv remarkably upregulated thymidine phosphorylase (TP) in tumors, which mediated the metabolic activation of 5-FU. Although TP is reported to promote angiogenesis and resistance, the combination of Bv and 5-FU resulted in anti-angiogenesis and vessel normalization in tumors, indicating that the elevated TP mainly contributed to the enhanced response to 5-FU. Bv also induced TP upregulation in LoVo cancer cells. Treatment with vascular endothelial growth factor receptor 2 (VEGFR2) antagonist apatinib and VEGFR2 silencing further confirmed TP upregulation. Bv and apatinib both enhanced the cytotoxicity of 5-FU in LoVo cells, but there was no synergism with adriamycin and paclitaxel. We further demonstrat...Continue Reading

References

Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N SekiT Kudo
Feb 5, 2003·Biochemical and Biophysical Research Communications·Ryuji IkedaShin-ichi Akiyama
Jun 19, 2007·Biochemical Pharmacology·Sandra LiekensJan Balzarini
Jul 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paxton V DicksonAndrew M Davidoff
Mar 25, 2008·Biochemical and Biophysical Research Communications·Ryuji IkedaKatsushi Yamada
May 13, 2009·Medicinal Research Reviews·Annelies BronckaersSandra Liekens
Jun 2, 2011·Nature Reviews. Drug Discovery·Peter Carmeliet, Rakesh K Jain
Jul 12, 2011·Physiological Reviews·Shom GoelRakesh K Jain
Jul 27, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Louisa von BaumgartenFrank Winkler
May 15, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rakesh K Jain
Oct 8, 2014·Circulation Research·Wei LiRoy L Silverstein
Nov 18, 2014·World Journal of Gastroenterology : WJG·Wei-Bin WangHong Shu
Mar 26, 2015·Brain : a Journal of Neurology·Candice ChapoulyGareth R John
Aug 25, 2015·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Yasir Y ElaminKathy Gately
Sep 9, 2016·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Sana QureshiJon D Herrington
Oct 27, 2016·European Journal of Medicinal Chemistry·Hriday Bera, Sridevi Chigurupati
Apr 28, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Virginia M RosenAijing Shang
May 21, 2017·International Journal of Clinical Oncology·Koji AndoUNKNOWN Kyushu Study Group of Clinical Cancer (KSCC)

❮ Previous
Next ❯

Citations

May 25, 2021·Journal of Natural Products·Guowei GongZhen Wen

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
xenografts
ELISA

Software Mentioned

MPLSM
ImageJ

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.